logo
Plus   Neg
Share
Email

Computacenter Says Q3 Trading Good; Outlook Remains In Line With Its View

Computacenter plc (CCC.L), a provider of IT infrastructure and services, said that trading across the Group in the third-quarter has been good. Revenue and profitability remain well ahead of its third-quarter 2018 year-to-date performance on a like for like basis before the positive impact of acquisitions.

The company noted that its outlook remains in line with its existing expectations, which were upgraded as per the Group's Trading Update on 31 July 2019.

"While the fourth quarter is always the most critical to the year's performance, the Board's confidence with its current expectations continues to strengthen as we progress through the year," the company said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Moderna said Tuesday that it has reached an agreement with the U.S. to initially supply 100 million doses of its experimental vaccine for COVID-19, mRNA-1273. The U.S. government has awarded up to $1.525 billion for the vaccine. Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites. The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement.
RELATED NEWS
Follow RTT